Central African Republic vs Rwanda: Number of HIV positive pregnant women receiving antiretrovirals
Central African Republic
2,874
in 2011
Rwanda
5,960
in 2011
Central African Republic rank
21st
Rwanda rank
18th
Number of HIV positive pregnant women receiving antiretrovirals over time
- Central African Republic
- Rwanda
How they compare
Rwanda currently reports 5,960 against 2,874 in Central African Republic, a difference of 3,086.
That makes Rwanda's figure about 2.1 times Central African Republic's.
Across all 6 years both countries report, Rwanda has been ahead every year.
Central African Republic ranks 21st and Rwanda ranks 18th of 38 countries.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,772 | 6,241 | 4,469 | Rwanda |
| 2010s | 2,874 | 5,960 | 3,086 | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Central African Republic or Rwanda?
- Rwanda, at 5,960 against 2,874 in Central African Republic as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Central African Republic and Rwanda?
- 3,086, with Rwanda ahead.
- How many years of comparable data are there for Central African Republic and Rwanda?
- 6 years are reported by both, from 2004 to 2011.
- How do Central African Republic and Rwanda rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Central African Republic ranks 21st and Rwanda ranks 18th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.